Pharmac rejects ripretinib funding for Whangārei nurse with rare cancer

Pharmac rejects ripretinib funding for Whangārei nurse with rare cancer

Michael MorrahSenior investigative reporter·NZ Herald·18 Oct, 2026 04:00 PM7 mins to read‌Juanita Bassett, who has a rare form of cancer, is having to fundraise to pay for a lifesaving drug which costs almost $20,800 per month. Video \ Jason Dorday Northland nurse Juanita Bassett has been diagnosed with a form of hereditary cancer so rare that fewer than 100 families have it worldwide. A drug could give the mother of two more time with her family but, as Michael Morrah reports, it’s prohibitively expensive, and she’s had to rely on

Original Source

Read the full article at Nzherald →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.